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Impact of porcine cytomegalovirus 
on long‑term orthotopic cardiac 
xenotransplant survival
Joachim Denner1,9*, Matthias Längin2,3,9, Bruno Reichart3, Luise Krüger1, Uwe Fiebig1, 
Maren Mokelke3, Julia Radan3, Tanja Mayr2, Anastasia Milusev4, Fabian Luther4, 
Nicoletta Sorvillo4, Robert Rieben4, Paolo Brenner5, Christoph Walz6, Eckhard Wolf7, 
Berit Roshani8, Christiane Stahl‑Hennig8 & Jan‑Michael Abicht2,3
Xenotransplantation using pig organs has achieved survival times up to 195 days in pig orthotopic 
heart transplantation into baboons. Here we demonstrate that in addition to an improved 
immunosuppressive regimen, non‑ischaemic preservation with continuous perfusion and control 
of post‑transplantation growth of the transplant, prevention of transmission of the porcine 
cytomegalovirus (PCMV) plays an important role in achieving long survival times. For the first time 
we demonstrate that PCMV transmission in orthotopic pig heart xenotransplantation was associated 
with a reduced survival time of the transplant and increased levels of IL‑6 and TNFα were found in 
the transplanted baboon. Furthermore, high levels of tPA‑PAI‑1 complexes were found, suggesting a 
complete loss of the pro‑fibrinolytic properties of the endothelial cells. These data show that PCMV 
has an important impact on transplant survival and call for elimination of PCMV from donor pigs.
Recently, consistent success in life-supporting (orthotopic) porcine cardiac xenotransplantation has been 
 reported1. In that study hearts from α1,3-galactosyltransferase-knockout (GTKO) pigs that express human 
membrane cofactor protein (CD46) and human thrombomodulin (hTM) had been transplanted into baboons 
and survival times up to 195 days were achieved. This is a milestone on the way to clinical cardiac xenotrans-
plantation which is urgently needed: The supply of human organs does not match the needs and many patients 
with terminal cardiac failure die while being on the waiting list.
Xenotransplantation with genetically modified porcine organs, as an alternative to allogenic (human-to-
human) procedures may be associated with the transmission of porcine microorganisms, among them the 
porcine endogenous retroviruses (PERVs). PERVs are integrated in the genome of all pigs and they are able to 
infect human  cells2. However, until now no PERV transmission was observed in the first preclinical (for review 
see ref.2) and clinical xenotransplantation  trials3,4. Whereas PERV-A and PERV-B, which are present in all 
pigs, infect human cells, PERV-C infects only pig cells and is not present in all  pigs2. However, recombinations 
between PERV-A and PERV-C can occur and the recombinant PERV-A/C is characterised by a higher replication 
 competence5. Therefore, it is highly recommended to use PERV-C-free pigs for xenotransplantation. Interest-
ingly, using CRISPR/Cas all retroviral sequences can be inactivated in the pig  genome7, however, it is still unclear 
whether this is needed for a safe  xenotransplantation9.
From the other viruses widely distributed in pigs, the porcine cytomegalovirus (PCMV) is of great  concern10. 
PCMV is related with the human cytomegalovirus (HCMV), also called human herpesvirus 5 (HHV-5). HCMV 
causes fatal infections in human organ transplant recipients if not treated, leading to end-organ disease, such as 
gastrointestinal ulceration, hepatitis, pneumonitis or retinitis. HCMV can also lead to systemic infection and 
disease once a threshold value of virus load is  exceeded11. In fact, HCMV has also been detected in the bowel 
mucosa where its reactivation has been suggested to lead to IL-6 release and inflammatory bowel  disease12.
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Meanwhile it was shown that PCMV is a roseolovirus and more closely related with human herpesviruses 6A, 
6B and 7 (HHV-6A, HHV-6B, and HHV-7)13. Therefore the thermology PCMV is to a certain degree mislead-
ing and should actually be porcine roseolovirus (PCMV/PRV)14. The International Committee on Taxonomy 
of Viruses (ICTV) classified this virus as suid betaherpesvirus  215. The closely related HHV-6 and HHV-7 were 
reported to be associated with numerous diseases, e.g., liver  failure16, multiple  sclerosis17 and Alzheimer  disease18. 
Furthermore, HHV-6 was found to promote cancer  development19 and accelerate acquired immunodeficiency 
syndrome (AIDS) in humans and  monkeys20,21, possibly by its immunosuppressive  property21–25.
Recently, by analysing a baboon recipient of orthotopic pig heart transplantation with a relatively short 
survival time (29 days) and hepatic failure, PCMV/PRV infection was observed in the  recipient26. In addition, 
PCMV/PRV transmission was also found in two other baboon recipients with 4 and 40 days of transplant 
survival. Immunohistochemical studies of the recipient baboons showed PCMV/PRV-expressing cells in all 
organs of the animal, most likely representing disseminated pig  cells27. These data, together with similar data 
on pig kidney xenotransplantions in non-human  primates28,29, suggest that PCMV/PRV significantly reduces 
the survival of pig xenotransplants. However, the mechanism through which PCMV/PRV reduces transplant 
survival is still  unclear30.
To better understand the impact of PCMV/PRV on pig transplant survival in orthotopic heart transplantation, 
numerous donor pig—baboon recipient pairs were retrospectively analysed for PCMV/PRV transmission. Here, 
we demonstrate for the first time that PCMV transmission in orthotopic pig heart xenotransplantation is associ-
ated with a reduced survival time of the transplant and indicate an impact of PCMV/PVR on cytokine release and 
coagulation. Furthermore, we show that other porcine viruses, which could potentially impact xenotransplant 
survival, including PERVs, hepatitis E virus (HEV), three porcine lymphotropic herpesviruses (PLHV) and the 
porcine circoviruses (PCV) 1 and 2, had not been transmitted.
Results
Transmission of PCMV/PRV into baboons after orthotopic pig heart transplantation. All 
baboon recipients received an immunosuppression including an induction therapy with an anti-CD20 antibody, 
anti-thymocyte-globulin and a monkey-specific anti-CD40 monoclonal antibody or humanized anti-CD40LPA-
Sylated as described in  detail1. Three groups of animals have been transplanted. In group I, donor organs were 
preserved with two clinically approved crystalloid solutions, the animals survived for less than 30 days (animal 
C, Table 1) and suffered from perioperative cardiac xenograft dysfunction (PCXD). To reduce the PCXD, in 
group II the pig hearts were preserved with an oxygenated albumin-containing hyperoncotic cardioplegic solu-
tion. Three of the four animals of this group lived for 18 (animal F), 27 (animal H) and 40 (animal I) days. A 
diastolic heart failure and subsequent congestive liver damage resulting from massive cardiac overgrow were 
observed in these animals. To prevent this, in group III baboon recipients were weaned from cortisone at an early 
stage and received antihypertensive treatment since pigs have a lower systolic blood pressure than baboons. In 
addition, a temsirolimus medication was used to counteract cardiac overgrowth. Two recipients in this group 
survived for 195 (animal O, Table 2) and 182 (animal N)  days1.
When the recipient baboon organs from group I and group II were analysed for PCMV/PRV transmission, 
PCMV/PRV was detected not only in the explanted pig heart but also in several different organs from all baboons 
except one (G; Table 1). Some of these animals (B, D, E) survived only one day and showed very low virus load in 
the explanted heart. However, after only three days an increase of the virus load was observed (animal A). When 
analysing the animals with the longer survival time, e.g., animal F with 18 days, animal H with 27 days, animal 
C with 30 days and animal I with 40 days, it became evident that PCMV/PRV replicates over time. Animal I 
Table 1.  PCMV infection in explanted pig hearts from different baboons. a Treatment groups according to 
Längin et al. 2019. b In brackets animal number as in Längin et al.  20191. c PCMV was also detected in the blood 
and the serum of baboon C (3 × 104 genome equivalent/ml blood) (Morozov et al., 2016, baboon 57)26, d No 
PCMV was found in different organs of baboon G (Fiebig et al. 2018, baboon 62)27, e PCMV was found in the 
spleen, liver, kidney, blood of baboon I (between 100 and 10,000 copies / 100 ng DNA) (Fiebig et al., 2018, 
baboon 64)27.
Animal number ID number Groupa PCMV in the explanted heart (copies per reaction) Survival time (days)
A (1)b 16,752 I 368 3
B (2) 16,754 I 30 1
C (3) 16,755 I 1.940.000c 30
D (4) 16,751 I 32 1
E (5) 16,753 I 62 1
F (6) 16,048 II 839.000 18
G (7) 17,138 II 0d 4
H (8) 17,140 II 39.200 27
I (9) 17,139 II 2.950.000e 40
P 17,494 III 33.000.000 15
Q 17,492 III 15.350.99 27
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(number 64 in publication 27) had not only a very high virus load in the explanted heart, but a high virus load 
was also found in the spleen, kidney, and blood (between 100 and 1000 copies/100 ng DNA) and cells expressing 
PCMV/PRV proteins were found in all organs of the transplanted  animal27. The longer the transplant was present 
in the recipient the higher was the virus load in the explanted and formalin/ethanol fixed pig heart (Table 1). This 
rule is operative only to a certain threshold of the virus load, above this threshold the survival time decreases 
due to the pathogenic effect of the virus.
When the recipient baboons of group III (early cortisone tapering, antihypertensive treatment and temsiroli-
mus) and their donor pigs were analysed, PCMV/PRV was found to be absent in the donor pigs and consequently 
in the transplanted baboons of animals with the longest survival times such as baboon J (90 days), baboon K 
(50 days), baboon L (90 days), baboon N (182 days) and baboon O (195 days) (Table 2). In contrast, PCMV/PRV 
was found in the donor pigs of transplanted baboons that showed a shorter survival rate like baboon P (15 days), 
baboon Q (27 days) and M (euthanized 10 days after transplantation because of severe iatrogenic complication) 
(Table 2). In the hearts explanted from animals P and Q astonishingly high copy numbers of PCMV/PRV were 
detected. Since all these data were obtained testing the formalin/ethanol fixed pig hearts, in addition the virus 
load in the frozen right ventricle of the heart explanted from baboon P was analysed and 48 million copies were 
found (33 million in the fixed heart). This is in the same magnitude, indicating that testing of fixed and frozen 
materials give approximately the same result.
Distribution of PCMV/PRV in pig and baboon organs. Using real-time PCR, the copy number (viral 
load) of PCMV/PRV was analysed in PBMCs and different organs of all donor pigs and in the organs of the trans-
planted baboons after removal of the transplanted heart, which was also analysed. As an example we illustrate in 
Fig. 1 the pair donor pig 6249 and the recipient baboon P. All other animals analysed had a similar pattern. The 
virus load in several organs of baboon I has been shown previously (animal 64 in reference 27). With exception 
of the skin, the viral load was high in all baboon organs (spleen, liver, muscle, kidney lung and lymph nodes) 
and donor pig organs (lung, spleen, liver, kidney and PBMCs), in agreement with the results in baboon  I27. The 
highest viral load was found in the explanted pig heart (Fig. 1). This is the main place of virus replication and 
this replication is possible due to the absence of the pig immune system, which could have reacted against the 
virus in the donor pig, and due to the strong immunosuppression in the baboon inhibiting its immune system.
Pathological findings and modulation of cytokine release. As mentioned above, baboons N and O 
from treatment group III, showed the longest survival time, 182 and 195 days, respectively, compared to baboons 
P and Q, which survived only 15 and 27 days. Interestingly, both baboons P and Q were characterized by patho-
logical and inflammatory changes, some of which might be the result of a PCMV/PRV infection, bearing in 
mind the broad disease spectrum induced by herpesviruses. Both animals showed signs of low-output heart fail-
ure at the end of the experiments, resulting in multi organ dysfunction as indicated by the pathological increase 
in functional parameters of liver, pancreas and kidney such as aspartate aminotransferase, creatine kinase, and 
lactate dehydrogenase. Decreased abdominal perfusion probably caused loss of mucosal barrier function in 
the gut, leading to translocation of intestinal microbes and to a strong increase of levels of interleukin-6 (IL-6) 
(Fig. 2). In fact, Klebsiella pneumonia was found in blood cultures of baboon Q one day before euthanasia. The 
Table 2.  Testing donor pigs and recipient baboons of transplantation group III for different viruses. *WB, 
Western blot assay; **indicating microchimerism; n.t., not tested.
Animal ID number
Transplant 
survival days
PCMV real-
time PCR
BaCMV real-
time PCR
HEV
PLHV1, 2
PCR
PLHV3
PCR
PERV
PCV1,2
PCRELISA/WB*
Real-time 
PCR
PERV
PCR
PERV-C
PCR WB*
Pig 5528 − − − ++ − ++ + −
Baboon J 17,186 90 − + n.t − − − +** − − n.t
Pig 5415 − − + − +++ − ++ + −
Baboon K 17,187 50 − + − − − − +** − − n.t
Pig 5420 − − + − +++ − ++ + −
Baboon L 17,290 90 − + − − − − +** − − n.t
Pig 5623 ++ − − + − ++ + −
Baboon M 17,188 10 ++ +++ n.t − − − +** − − −
Pig 5803 − − − +++ − ++ + −
Baboon O 17,493 195 − + − − − − +** − −
Pig 5807 − − − +++ − ++ + −
Baboon N 17,491 182 − + − − − − +** − − −
Pig 6249 ++ − − +++ − ++ + −
Baboon P 17,494 15 +++ + − − − − +** − − −
Pig 6253 + − − ++ − ++ + −
Baboon Q 17,492 27 ++ + − − − − +** − − −
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increase in IL-6 most probably is not due to treatment with an IL-6-receptor antagonist tocilizumab, since treat-
ment began at the very beginning of transplantation and was given to all animals as part of the treatment proto-
col, including animals N and O that did not show high plasma levels of the cytokine. To confirm these data and 
to perform a broader analysis of further pro- and anti-inflammatory cytokines, a cytometric bead array (CBA) 
assay for non-human primate Th1/Th2 cytokines as well as an IL-10 ELISA were performed. The obtained data 
confirmed the strong increase of IL-6 (Fig. 3A), and also revealed a substantial increase of tumour necrosis fac-
tor (TNF) in baboons P and Q with the PCMV/PRV-positive hearts (Fig. 3B). No alterations were observed in 
serum levels of the proinflammatory cytokines interferon γ (IFN γ) (Fig. 3C) and interleukin 2 (IL-2) (Fig. 3D) 
as well as the anti-inflammatory cytokines interleukin-4 (IL-4) (Fig.  3E), interleukin-5 (IL-5) (Fig.  3F), and 
interleukin-10 (IL-10) (data not shown). 
Interestingly, histological examination of the explanted pig hearts from baboons N, O, P, and Q revealed 
marked perivascular and moderate edema in otherwise unremarkable myocardial tissue (Fig. 4A, B). In par-
ticular, no morphologic signs of cellular or antibody-mediated transplant rejection was found (Fig. 4B), and in 
parallel no elevated levels of non-galactose-a1,3-galactose reactive IgM and IgG were measured (not shown), 
indicating that immunological rejection was not the cause of the reduced survival observed in animals P and Q.
Figure 1.  Viral load (copies per 100 ng DNA) in different organs of baboon P after explantation of the pig 
heart, in PBMCs and different organs of the donor pig and in the pig heart after explantation as measured by 
real-time PCR.
Figure 2.  Kinetics of the IL-6 amount in the blood of transplanted baboons as measured by ELISA. The baboon 
recipients of the treatment group III are indicated (N, O, P, Q).
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High levels of tPA‑PAI‑1 complex. To analyse whether animals infected with PCMV/PRV could pre-
sent alteration in the coagulation system, tissue plasminogen activator (tPA) and plasminogen activator inhibi-
tor 1 complexes (tPA-PAI-1) were measured in plasma samples by an  ELISA31. Interestingly, we observed that 
baboons P and Q, which presented clear pathological alterations, also had very high levels of tPA-PAI-1 com-
plexes (Fig. 5). This indicates a hypercoagulable state of the two animals and a decrease in fibrinolysis, originated 
most probably by endothelial cell damage.
Expression of BaCMV afterPCMV/PRV transmission. Since all baboon recipients carried BaCMV, we 
looked into a possible activation of this virus, which may also influence the survival time of the transplant and 
recipient. Recently a significantly increased expression of BaCMV in plasma of baboon I after transplantation 
of a PCMV/PRV-positive pig heart was  measured27. Although analysis of BaCMV in all baboon organs (liver, 
kidney, spleen and lung) showed a high virus load, a clear and measurable increase of the BaCMV virus load in 
the blood after transplantation as was found in animal I was not observed (Table 2). Moreover, no differences in 
the BaCMV viral load in baboons with a long or a short survival time was observed. This highly suggests that 
activation of BaCMV is not the cause of early loss of the transplanted pig heart.
Prevalence and transmission of other porcine viruses. In order to analyse whether other porcine 
viruses were present in the donor pig and were transmitted to the recipient, which also may influence the sur-
vival time of the xenotransplant, both Western blot and PCR/RT-PCR analysis was performed to detect PERV, 
PLHV, PCV and HEV in both pig and baboon tissues. PLHV-1 and PLHV-2 had been detected in all donor pigs 
used in this study. Despite this, no transmission of these viruses to the recipient baboons was observed (Table 2). 
Although Western blot analyses showed HEV infection in the donor pigs of baboons G, I, K and L, detection of 
HEV by RT-PCR gave negative results in all donor pigs, indicating that the virus was not present in their blood. 
However, transmission to the recipients was not observed (Table 2). Indeed, all baboons were negative for HEV 
infection independently to the test used for analysis, e.g., no positive RT-PCR reactions and no positive ELISA 
or Western blot analyses were found.
PERV was detected as expected in all donor pigs by PCR using specific primers binding to a highly conserved 
region in the polymerase (pol) gene (Table 2). In fact, these primers recognise both PERV-A, PERV-B and PERV-
C. Since PERV-A and PERV-B is present in all  pigs2, a PCR using primers specific for the env region of PERV-C 
was performed, and PERV-C was detected in all donor pigs.
PERV was also analysed in baboon samples using the pol specific PCR, detecting PERV-A, PERV-B and 
PERV-C. As shown in Table 2, these sequences were detected in all baboon blood samples, however the detec-
tion of PERV in the blood samples might be due to circulating cellular DNA from dead transplant cells or 
from circulating pig cells, a phenomenon called microchimerism. This was confirmed by the finding of porcine 
Figure 3.  Increased IL-6 and TNF serum levels in baboons with PCMV/PRV-positive hearts. BD CBA Non-
human primate Th1/Th2 kit was used to measure plasma levels of (A) IL-6, (B) TNF, (C) IFN γ, (D) IL-2, (E) 
IL-4 and (F) IL-5 one week before transplantation (day -7) and during the experiment (day 13, 26, 180 and 194, 
respectively) in baboons N, O, P and Q. Dotted lines indicate lowest standard concentration.
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glycerinaldehyde-3-phosphat-dehydrogenase (GAPDH) by a specific PCR. Since the copy number of PERV-C 
in pig cells is much lower compared to the copy number of PERV-A and PERV-B, PERV-C sequences could not 
be detected in the blood of the baboons. Moreover, Western blot analysis showed no anti-PERV antibodies in 
all baboon samples, clearly indicating absence of infection (Supplementary Fig. 1). In summary, no other pig 
viruses which could influence the survival time of the transplant had been transmitted to the recipient baboons.
Discussion. Recently, survival times of 182 and 195  days after preclinical orthotopic pig-to-baboon 
xenotransplantation were achieved by several measures that include an improved immunosuppressive regi-
Figure 4.  A Histopathologic evaluation of the explanted pig hearts from baboons N to Q. Arrowheads mark 
perivascular and arrows moderate edema in otherwise unremarkable myocardial tissue in all specimens. Scale 
bars indicate 250 μm. B. Histopathologic evaluation revealed perivascular (arrowhead) and interstitial (arrow) 
edema in otherwise unremarkable myocardial tissue in all specimens. In particular, no morphologic signs of 
cellular or antibody-mediated transplant reaction was found. Scale bars indicate 100 µm.
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men, non-ischaemic preservation with continuous perfusion and control of post-transplantation growth of the 
 transplant1. Here, for the first time, we show that the use of organs from PCMV/PRV-positive pigs in this life-
supporting model is associated with a reduction of the transplant survival time.
Our data on reduction of the survival time of PCMV/PRV-positive pig hearts orthotopically transplanted into 
baboons supports previous findings in other preclinical trials on kidney  xenotransplantations28,29,32–36. In these 
studies, PCMV/PRV was found in all organs of the baboon recipients, with the highest copy numbers in liver, 
lung and  kidney33. An increased PCMV/PRV virus load was found in 22 different pig xenotransplants with a 
survival time between 7 and 32 days in  baboons33. The presence of PCMV/PRV was usually found associated with 
consumptive coagulopathy (CC)34. However, there was no correlation between PCMV/PRV infection and CC, 
but lower levels of PCMV/PRV infection were always associated with a prolonged transplant  survival34. When a 
heterotopic pig heart transplantation was performed in baboons, the survival time of the transplant was shorter 
when the organs were PCMV/PRV-positive (median 20 days), compared with PCMV/PRV-negative transplants 
(median 53 days)35. Most importantly, early weaning was shown to prevent PCMV/PRV infection of the  pigs35. 
Organs from PCMV/PRV-free animals due to early weaning did not induce CC. Unfortunately, PCMV/PRV 
had been shown to have a reduced susceptibility to ganciclovir which is very effective in inhibiting  HCMV36. 
Ganciclovir was also given to the baboons in the present study. When kidneys from GTKO pigs were transplanted 
into baboons, the median survival time of the kidneys from PCMV/PRV-positive animals was 14.1 days, the 
survival time of kidneys from PCMV/PRV-negative animals was 48.8 days and that of kidneys from PCMV/
PRV-negative animals after a Caesarean delivery was 53  days28, clearly demonstrating that the transmission of 
PCMV/PRV reduced significantly the kidney transplant survival. A similar effect was observed, when GTKO 
pig kidneys were transplanted into cynomolgus monkeys. Whereas the survival time of kidneys from PCMV/
PRV-free animals was 28.7 days, the presence of PCMV/PRV reduced the survival time to 9.2  days29.
The immunosuppression used in this trial is based on an induction therapy with an anti-CD20 antibody, 
anti-thymocyte-globulin and a monkey-specific anti-CD40 monoclonal antibody or humanized anti-CD40LPA-
Sylated. During maintenance therapy methylprednisolone was reduced gradually, whereas mycophenolate mofetil 
and anti-CD40 monoclonal antibody or anti-CD40L PASylated Fab treatment remained constant as described 
in  detail1. This strategy has been used successfully in other  laboratories2 and it was approved by the local Upper 
Bavarian Government. The selected immunosuppressive regimen will be easily translated into a future pig-to-
human system. There are of course other immunosuppressive agents such as blocking leukocyte costimulatory 
 molecules37, expression of CTLA4-Ig, which disrupts co-stimulatory pathways, and PD-L1, which activates 
T-cell inhibitory  pathway38, and co-receptor blockage targeting CD4 and  CD839, however these methods have 
not been applied in solid organ xenotransplantation, but mainly to prevent rejection of embryonic stem cells.
Our findings that PCMV/PRV induces IL-6 and TNF release and increases the amount of t PAI-1/tPA com-
plexes significantly contributes to the understanding of the mechanism of action of PCMV/PRV on pig trans-
plant survival. However, there are still open questions. It is still unclear, whether PCMV/PRV can infect baboon 
cells. Using PCR and immunohistochemical methods, PCMV/PRV was found in all organs of the transplanted 
baboon (Fig. 1 and reference 27), however it is unclear whether the cells stained positive with a specific antise-
rum against PCMV/PRV are disseminated PCMV/PRV-producing pig cells or infected baboon cells. It is also 
unclear whether PCMV/PRV can infect human cells. One report claimed infection of human  cells40, whereas 
another report showed that human cells cannot be infected with PCMV/PRV41. In our preliminary experiments 
incubating PBMCs from PCMV-positive pigs with human 293 cells, no infection of the human cells was observed 
(unpublished data). Since different non-human primate species (cynomolgus monkeys, baboons) showed a 
Figure 5.  Measurement of tPA-PAI-1 complexes in the blood of baboons J65-Q74.
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similar reduction of the survival time (ref. 28, 29 and this study), it seems very likely that the same may happen 
in humans. It is important to note, that the high virus load in the recipient baboon, independent whether the 
virus was produced by the pig transplant or by infected baboon cells, caused rejection of the transplant mainly 
by acting on the cytokine production and coagulation and this cannot be analysed in a human system in vitro.
There are other factors which may contribute to the reduction of pig transplant survival time. A consumptive 
coagulopathy was often observed in non-human primates with pig  xenotransplants34,42–44. Although in vitro an 
activation of the porcine tissue factor (TF) in porcine aortic endothelial cells by a PCMV/PRV infection was 
observed, no correlation between TF expression and PCMV/PRV infection was observed in vivo34. An enhanced 
expression of ICAM-1 (intracellular adhesion molecule I) and MHC (major histocompatibility complex) class 
II in the pig transplant in baboons suggests an activation of endothelial  cells28. PCMV/PRV is like many other 
viruses immunosuppressive and was shown to modulate the expression of immune-related genes in pig immune 
 cells22. Furthermore, a PCMV/PRV infection of pigs is usually associated with opportunistic bacterial infections 
on the basis of the suppressed immune  system23 and a transcriptome analysis of PCMV/PRV-infected thymuses 
showed an up- and downregulation of immune-regulatory  genes24. However, considering the strong pharmaceu-
tical immunosuppression of the animals in order to prevent rejection of the pig organ, the immunosuppressive 
properties of PCMV/PRV may not be important for the PCMV/PRV-induced pathogenesis.
An upregulation of IL-6 and TNFα in several allo- and xenotransplantation studies has previously been 
described indicating pathological roles for these cytokines (for review  see45). IL-6 is one of the most important 
cytokines during an infection, along with IL-1 and  TNF46. TNF is a cytokine involved in systemic inflamma-
tion and is a critical effector molecule in the immune response to viral  pathogens47. TNF is able to inhibit viral 
replication and respond to sepsis via IL-1- and IL-6-producing cells.
The pleiotropic effects of IL-6 include the stimulation of antibody production and induction of acute-phase 
proteins, such as C-reactive protein (C-RP) and  fibrinogen48. In a pig-to-baboon xenotransplantation study in 
which kidneys, hearts and artery patches from GTKO or GTKO/CD46-transgenic pigs were transplanted, sig-
nificantly increased IL-6 levels were  observed49. High levels of fibrinogen and C-RP positively correlated with 
IL-6 levels and C-RP depositions in the heart and kidney xenotransplants were detected. These data indicate 
that the up-regulation of IL-6 might promote systemic inflammation and together with the subsequent induc-
tion of C-RP leads to a dysregulation of coagulation after  xenotransplantation49. Some studies suggest that the 
administration of tocilizumab, an antibody raised against the IL-6 receptor, reduced antibody-mediated rejection 
in post-transplantation and improved allograft  survival50 or reduced C-RP levels and other factors to alleviate 
consumptive  coagulopathy51–54. Tocilizumab reacts with the human and baboon IL-6 receptor, but not with the 
pig IL-6  receptor54. Blocking the baboon IL-6 receptor may lead to higher circulating levels of IL-6n in the blood 
and this may be detrimental to pig xenotransplant survival due to IL-6 stimulation of pig cells in the transplant.
Additionally, in an in vitro model in which porcine aortic endothelial cells or PBMCs were incubated with 
human umbilical vein endothelial cells (HUVECS) an upregulation of human inflammatory cytokines including 
TNFα, chemokines and tissue factors by porcine IL-6 and TNFα was observed. These data indicate that porcine 
IL-6 and TNFα can stimulate recipient cells and thereby promote coagulation as well as inflammation upon 
 xenotransplantation55. Besides IL-6 also TNFα was reported to be up-regulated in baboons after pig heart trans-
plantation and seems to act as a key pro-inflammatory cytokine in xenotransplant  rejection56,57. TNFα was also 
detected during acute rejection in porcine islets transplanted into non-human primates  NHPs58. Furthermore, 
the TNFα antagonist etanercept was shown to suppress coagulation dysfunction in xenotransplantation and to 
contribute to pig kidney survival in  baboons59.
Cytokines released by immune cells can also directly influence the proliferation cardiomyocytes. Whereas 
murine Treg cells promote proliferation of murine neonatal cardiomyocytes through paracrine factors including 
 cytokines80, TNFα, IFNα and IL-17A produced by  CD4+ Th1 and Th17 cells reduced the number of cultured 
murine  cardiomyocytes61. Therefore these cells directly inhibited proliferation and promoted the apoptosis of 
neonatal mouse cardiomyocytes.
Despite the seemingly overwhelming evidence for the role of PCMV/PRV, there may also be other factors 
contributing to the reduced survival rates. As explained elsewhere in  detail1, xenotransplantation experiments 
in groups I and II failed because of insufficient organ preservation and overgrowth of the transplant, respec-
tively. Baboons P and Q (group III) were euthanized because of beginning multi-organ failure, which might be 
attributed to other causes than PCMV/PRV: Baboon P had received a graft of borderline small size and baboon 
Q developed recurrent pericardial effusions. Relative size mismatch may lead to systolic heart failure, whereas 
recurrent effusions may lead to pericardial tamponade and diastolic insufficiency, both eventually causing multi-
organ failure. Microbial translocation and opportunistic infections were observed in animals P and Q; both are 
common after infection with immunosuppressive viruses including human immunodeficiency virus (HIV)44, 
but can also be attributed to immunosuppressive treatment by itself.
It was clearly shown that PCMV/PRV replicates in the transplanted heart (Fig. 1, Table 1). Already at day 
three an increase of the copy number in the heart was observed, reaching much higher copy numbers later. It may 
be suggested that the pharmaceutical immunosuppression given to prevent rejection and possibly the PCMV/
PRV-induced immunosuppression plays an important role in allowing increased PCMV/PRV replication. For 
comparison, previous studies of the replication rate of HCMV in humans showed that its dynamics are rapid, with 
a doubling time of viraemia of approximately 1  day63. In analogy to the HCMV infection, where a clear threshold 
relationship was observed, e.g., the virus causes disease once a threshold value of viral load is  exceeded11, such 
a threshold seems also important in the case of PCMV. In this context, a viral load of 2 to 3 million copies may 
be tolerable until day 30–40, whereas higher viral loads further reduce the survival time.
Since other viruses could also interfere with the survival time of the transplants, activation of BaCMV in the 
transplanted baboon and transmission of HEV, PERV, PCV1, PCV2, as well as PLHV1, 2 and 3 was analysed. 
All baboons used in these investigations carried BaCMV, which is common in baboons. In one case a strong 
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activation of BaCMV after transplantation of a PCMV-positive pig heart was observed (baboon I)27. In all other 
cases a direct activation of BaCMV could not be observed. Concerning BaCMV activation, in another preclinical 
trial transplanting pig kidneys into baboons, it was also observed in control animals without transplantation, 
but with the corresponding immunosuppression, indicating that immunosuppression alone is able to activate 
 BaCMV64.
HEV, genotype 3, is a well-known zoonotic virus, it is frequently transmitted to humans by undercooked meat 
or contact, but also by manure-contaminated fruits and water, and it induces chronic infection in immunosup-
pressed patients and severe liver disease in patients with an underlying liver  failure65. However, until now no HEV 
transmission was reported in all preclinical and clinical xenotransplantation trials, including this study (Table 2).
PERV DNA was observed in the circulation of baboons following transplantation of a pig heart (Table 2). 
However, this observation appears to be due to circulating DNA from dead transplant cells or persistent pig cell 
microchimerism.
PCV1 and PCV2 were not present in the donor pigs and, logically, could not be transmitted to the recipients. 
Meanwhile it was published, that four donor pigs (animals 5803, 5807, 6249, 6253) were infected with PCV3 
and that this virus was transmitted in all four cases to the baboon recipients (baboons O, N, P, Q)66. PCV3 is 
a newly described member of the virus family Circoviridae, it is highly distributed among farms pigs and wild 
boars worldwide (for review see Reference 67). Similarly to the situation with PCV2, PCV3 was found in healthy 
animals as well as in animals suffering from different diseases, suggesting that coinfections with other viruses are 
necessary for the pathogenic potential. PCV3 does not seem to influence the survival time because baboons with 
the highest survival time (animal N—182 days, O—195 days) and animals with low survival times (P—15 days, 
Q—27 days) were infected with PCV3. In contrast, there was a clear correlation between the infection with 
PCMV and survival (15 and 27 days versus 182 and 195 days).
Although all donor pigs were infected with PLHV-1 and PLHV-2, no transmission to the baboon recipients 
was observed, PLHV-3 was not found in the donor pigs. PLHV-1, -2, and -3 belong to the subfamily Gamma-
herpesvirinae in the Herpesviridae family. The pathogenicity of PLHV in pigs under natural conditions is still 
unclear. Under experimental conditions PLHV-1 is associated with post-transplant lymphoproliferative disease 
(PTLD) in miniature pigs following allogeneic haematopoietic stem cell  transplantation68,69. The clinical symp-
toms of experimental porcine PTLD, such as fever, lethargy, anorexia, high white blood cell count and palpable 
lymph nodes, are similar to those of human PTLD, a serious complication of solid organ and allogeneic bone 
marrow transplantation, which was linked to a human gammaherpesvirus, Epstein-Barr virus (human herpes 
virus-4, HHV-4)70.
In order to prevent transmission of porcine viruses after xenotransplantation, elimination programs had been 
proposed which are based on selection and isolation of virus-negative animals, vaccination or treatment with an 
effective antiviral drug (both are not available in the case of PCMV/PRV), early weaning, colostrum deprivation, 
Caesarean delivery or embryo transfer. Although PCMV/PRV can be transmitted via  placenta71,72, successful 
elimination can be achieved by early  weaning35,73, providing virus-free animals for a safe xenotransplantation.
Methods
Animals and transplantations. All details of the donor pigs, the baboon recipients and the transplanta-
tion procedures were described in reference 1.
Immunosuppression. All baboon recipients received an immunosuppression including an induction 
therapy with an anti-CD20 antibody, anti-thymocyte-globulin and a monkey-specific anti-CD40 monoclonal 
antibody or humanized anti-CD40LPASylated as described in  detail1. The group III baboon recipients analysed 
here were weaned from cortisone at an early stage and received antihypertensive treatment. In addition, a tem-
sirolimus medication was applied.
Plasma and blood collection. Blood sampling from adult sows was performed without sedation under 
manual fixation. Whole blood was drawn from the jugular vein with single‐use needles (Ehrhardt Medizin-
produkte, Geislingen, Germany) into lithium heparin and serum Monovettes (Sarstedt, Nümbrecht, Germany). 
Blood from the baboons was taken using a central venous catheter.
Ethics statement. Both the generation of transgenic animals, as well as interventions on re-cloned animals, 
were performed with permission of the local regulatory authority. Applications were reviewed by the ethics com-
mittee according to §15 TSchG German Animal Welfare Act. The xenotransplantation experiment was approved 
by the Government of Upper Bavaria, Munich, Germany. Housing, feeding, environmental enrichment, and 
steps taken to minimise suffering, including the use of anaesthesia and method of sacrifice, was in accordance 
with the recommendations of the Weatherall report “The use of non-human primates in research”.
Testing for PCMV/PRV. PCMV/PRV testing was performed as  described25 using specific primers (Table 3). 
Briefly, DNA was extracted from sera, blood and organs of the pigs using the DNeasy Blood &Tissue kit (Qia-
gen GmbH, Hilden, Germany). DNA was quantified using a NanoDrop ND-1000 (Thermo Fisher Scientific 
Inc., Worcester, MA, USA). To screen for PCMV, a real-time PCR using described  primers26 and the SensiFast 
probe no ROX kit was performed according to supplier recommendations (Bioline GmbH, Germany). DNA 
from formalin-fixed tissues was extracted by using the QIAamp DNA FFPE Tissue Kit (QIAGEN), following 
the manufacturer’s instructions. As the starting material was not paraffin-embedded but only formalin-fixed tis-
sue, we started the process by cutting the tissue into small pieces, added buffer and proteinase and followed the 
manufacturer’s protocol by incubating at 56 °C. A detection limit of 20 copies was determined for the reported 
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PCR  method26. Various amounts (25—250 ng) of DNA were used for testing. The reaction mixture contained 
300 nM of both primers, and 250 nM of the probe (Table 3) in a final volume of 20 µL. The following conditions 
for amplification were used: denaturation at 95 C for 5 min, and 45 cycles of amplification with denaturation at 
95 C for 15 s, annealing at 56 C for 30 s and extension at 72 °C for 30 s. Reporter fluorescence was measured using 
the CFX96 Toich Real-time PCR detection system (Bio-Rad, Hercules, CA, USA).
Testing for BaCMV. To test for BaCMV, a real-time PCR was performed using described  primers32 (Table 3), 
but the enzymes and conditions had been changed: Denaturation at 95 °C for 5 min, and 45 cycles of amplifica-
tion with denaturation at 95 °C for 15 s, annealing at 57 °C for 30 s and extension at 72 °C for 30 s.
Testing for PERV. To test for PERV, a PCR was performed using primers for the pol sequence (Table 3) as 
 described4. This PCR detects PERV-A, PERV-B and PERV-C, since the pol region is highly conserved. To test 
for PERV-C, a PCR was performed using primers specific for the env region of PERV-C (Table 3)74,75. A Western 
blot analysis was performed using recombinant p27Gag protein, p15E protein and gp70 protein as well as goat 
sera against these recombinant proteins as positive control as  described4,76.
Testing for HEV. To test for HEV, a real-time PCR was performed as  described77 using specific  primers78. 
Western blot analysis was performed using two overlapping recombinant ORF2 proteins of HEV genotype 3 as 
 described77. On protein contained the immunodominant epitope (GT3-Ctr, aa 326–608, 32 kb)79, the other was 
with a glutathione-S-transferase tag (aa452-617, 44.5 kb, Orosperc, Ness Ziona, Israel).
Testing for PLHV. To test for PLHV-1, PLHV-2 and PLHV-3 two PCR methods and specific primers 
(Table 3) were used as  described80–82.
Testing for PCV. To test for PCV1 and PCV2, a PCR method and specific primers (Table 3) were used as 
 described63, using specific  primers83.
Measurement of cytokines. IL-6 release over time was studied in the Laboratoriumsmedizin of the 
Munich University using an ELISA (Roche, Elecsys IL-6).
Table 3.  Primers and probes.
Primers Used for PCR Sequence 5′–3′ Nucleotide position Accession number References
Primers used for PCR
PLHV-1,-2 (747) fw
PLHV-1,-2 (747) rev
CAY GGT AGT ATT TAT TCA GACA 
GAT ATC CTG GTA CAT TGG AAAG 
21,146–21,167
21,488–21,467 AY170317.1 Ehlers
81 
PLHV-3 (905) fw
PLHV-3 (905) rev
ACA AGA GCC TTA GGG TTC CAA ACT 
GTG TCC AGT GTT GTA ATG GAT GCC 
13,472–13,495
13,727–13,704 AY170316.1 Chmielewicz et al.
82
PCV1 fw (F41)
PCV1 rev (B42)
ATA CGG TAG TAT TGG AAA GGT AGG G
ACA CTC GAT AAG TAT GTG GCC TTC T Mankertz et al.
84 
PCV2 fw (F66)
PCV2 rev (B67)
GGT TTG TAG CCT CAG CCA AAGC 
GCA CCT TCG GAT ATA CTG TCA AGG 
567–546
152–175 KT868491.1 Mankertz et al.
66 
PERV env C fw
PERV env C rev
CTG ACC TGG ATT AGA ACT GG
ATG TTA GAG GAT GGT CCT GG
6606-6625
6867–6886 AM229312 Takeuchi et al.
74
Primers and probes used for real-time PCR
pGAPDH fw
pGAPDH rev
pGAPDH probe
ACA TGG CCT CCA AGG AGT AAGA 
GAT CGA GTT GGG GCT GTG ACT 
HEX-CCA CCA ACC CCA GCA AGA GCA 
CGC -BHQ1
1083–1104
1188–1168
1114–1137
NM_001206359.1 Duvigneau et al.85
JVHEVF
JVHEVRJVHEVProbe
GGT GGT TTC TGG GGT GAC 
AGG GGT TGG TTG GAT GAA 
FAM-TGA TTC TCA GCC CTT CGC -BHQ
5261–5278
5330–5313
5284–5301
M73218 Jothikumar et al.60
PCMV fw
PCMV rev
PCMV probe
ACT TCG TCG CAG CTC ATC TGA 
GTT CTG GGA TTC CGA GGT TG
6FAM-CAG GGC GGC GGT CGA GCT 
C-BHQ!
45206–45226
45268–45249
45247–45229
Mueller et al.33
BaCMV real fw
BaCMV real rev
BaCMV probe
GTT TAG GGA ACC GCC ATT CTG 
GTA TCC GCG TTC CAA TGC A
6FAM-TCC AGC CTC CAT AGC CGG 
GAAGG-BBQ
Mueller et al.32
huGAPDH fw
huGAPDH rev
huGAPDH probe
GGC GAT GCT GGC GCT GAG TAC 
TGG TCC ACA CCC ATG ACG A 
HEX-TTC ACC ACC ATG GAG AAG GCT 
GGG -BHQ1
3568–3587
3803–3783
3655–3678
AF261085 Behrendt et al.86
PERV Pol  fw
PERV Pol rev
PERV Pol probe
CGA CTG CCC CAA GGG TTC AA
TCT CTC CTG CAA ATC TGG GCC 
6FAM-CAC GTA CTG GAG GAG GGT CAC 
CTG -BHQ1
HM159246 Yang et al.8
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The BD™ CBA Non-Human Primate (NHP) Th1/Th2 Cytokine Kit (BD Biosciences, Heidelberg) was used 
to measure IL-2, IL-4, IL-5, IL-6, TNF and IFN γ in baboon serum samples according to the manufacturer´s 
instructions. Serum samples were diluted 1:20 before use. Samples were acquired by use of a LSR II cytometer 
(BD Biosciences). To measure IL-10 serum levels the IL-10 Monkey ELISA Kit (Thermo Fisher, Waltham) was 
used according to the manufacturer´s instructions.
Measurement of coagulation. The PAI-1/tPA complexes were measured in baboon EDTA plasma sam-
ples by a commercial ELISA kit for the measurement of human PAI-1/tPA complexes (Abcam, ab192151, https 
://www.abcam .com/human -pai1t pa-elisa -kit-ab192 151.html).
Tissue processing and histological staining. All myocardial specimens were fixed in 4% neutral-buff-
ered formalin and embedded in paraffin. Tissue sections were then stained with hematoxylin and eosin.
Western blot analysis. To detect antibodies against PERV in baboons, recombinant surface envelope pro-
tein gp70, transmembrane envelope protein p15E and core protein p27 were used as  described4,76. As control 
goat antisera against these recombinant proteins were used. Secondary anti-goat IgG and anti-human antibodies 
were used and the assay was developed using alkaline phosphatase. To detect antibodies against HEV in pigs 
and baboons, a recombinant genotype 3 (GT3) ORF 2 core  antigen61 and a recombinant 44.5 kDa protein with 
a glutathione-S transferase (GST) tag fused to the ORF2 fragment (Prospec, Ness Ziona, Israel) was  used77. 
Alkaline phosphatase conjugated antibodies were used and the reaction was developed using NBT (nitro-blue 
tetrazolium chloride)-BCIP (5-bromo-4-chloro-3′-indolyphosphate p-toluidine salt) substrate.
Data availability
The data that support the findings reported herein are available on reasonable request from the corresponding 
author.
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